Note: Ingredients listed on restricted chemical lists
EC/CAS
247-722-4/26471-62-5
Name of the chemical
m-Tolylidendiisocyanat
Concentration
>=5-<10
General Information
Version
4.0
Revision date
2015-09-14
Product name
SOLITHANE S 113
CAS No.
67700-43-0
1.2.1 Relevant identified uses
Polymer
1.2.2. Uses advised against
Reserved for industrial and professional use on use
Emergency telephone
+44 (0) 1235 239 670
Icons in SDS
Company Information
company name
Chemtura Manufacturing UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
msdsrequest@chemtura.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H330, H334, H351
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H317 May cause an allergic skin reaction. H330 Fatal if inhaled. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H351 Suspected of causing cancer.
Supplemental label elements
EUH204 Contains isocyanates. May produce an allergic reaction.
Prevention
P260 Do not breathe dust/ fume/ gas/ mist/ vapours/ spray. P280 Wear protective gloves.
Response
P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P304 + P340 IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P308 IF exposed or concerned: P310 Immediately call a POISON CENTER or doctor/ physician.
2.3 Other hazards
This substance is not considered to be persistent, bioaccumulating and toxic (PBT).
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Acute toxicity, Category 2 H330: Fatal if inhaled. Respiratory sensitisation, Category 1 H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction. Carcinogenicity, Category 2 H351: Suspected of causing cancer.
